Skip to content

13F-HR filed by BloombergSen Inc.

BloombergSen Inc. filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-09, with 11 holding rows worth $1,023,244,000.

Accession
0001140361-16-085554
Filed
2016-11-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 11 entries on the cover page, a total value of $1,023,244,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,023,244,000 with VALUE read as thousands by filing date, 13F file number 028-13755. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHARTER COMMUNICATIONS INC N16119P108COM757,444$204,487,000thousands by filing date
CREDIT ACCEP CORP MICH225310101COM813,537$163,578,000thousands by filing date
INTERNATIONAL GAME TECHNOLOGG4863A108SHS USD6,508,881$158,687,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM1,665,913$117,497,000thousands by filing date
Wells Fargo & Company949746101COM2,233,295$98,890,000thousands by filing date
COLLIERS INTL GROUP INC SUB VTG SHS194693107Stock1,726,128$72,618,000thousands by filing date
Citigroup Inc.172967424COM1,465,400$69,211,000thousands by filing datecall
PRA Group Inc69354N106COM1,948,627$67,306,000thousands by filing date
AON PLCG0408V102SHS CL A563,905$63,434,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM306,900$7,534,000thousands by filing datecall
VALEANT PHARMACEUTICALS INTL91911K102COM66$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-16-085554this filing2016-11-09acceptance time not in the bulk data set